Abstract:Genes influencing opioid use disorder (OUD) biology have been identified via genome-wide association studies (GWAS), gene expression, and network analyses. These discoveries provide opportunities to identifying existing compounds targeting these genes for drug repurposing studies. However, systematically integrating discovery results and identifying relevant available pharmacotherapies for OUD repurposing studies is challenging. To address this, we’ve constructed a framework that leverages existing results and drug databases to identify candidate pharmacotherapies. For this study, two independent OUD related meta-analyses were used including a GWAS and a differential gene expression (DGE) study of post-mortem human brain. Protein-Protein Interaction (PPI) sub-networks enriched for GWAS risk loci were identified via network analyses. Drug databases Pharos, Open Targets, Therapeutic Target Database (TTD), and DrugBank were queried for clinical status and target selectivity. Cross-omic and drug query results were then integrated to identify candidate compounds. GWAS and DGE analyses revealed 3 and 335 target genes (FDR q<0.05), respectively, while network analysis detected 70 genes in 22 enriched PPI networks. Four selection strategies were implemented, which yielded between 72 and 676 genes with statistically significant support and 110 to 683 drugs targeting these genes, respectively. After filtering out less specific compounds or those targeting well-established psychiatric-related receptors ( and ), between 2 and 329 approved drugs remained across the four strategies. By leveraging multiple lines of biological evidence and resources, we identified many FDA approved drugs that target genes associated with OUD. This approach a) allows high-throughput querying of OUD-related genes, b) detects OUD-related genes and compounds not identified using a single domain or resource, and c) produces a succinct summary of FDA approved compounds eligible for efficient expert review. Identifying larger pools of candidate pharmacotherapies and summarizing the supporting evidence bridges the gap between discovery and drug repurposing studies.

Identifying compounds to treat opiate use disorder by leveraging multi-omic data integration and multiple drug repurposing databases

Drug repurposing for opioid use disorders: integration of computational prediction, clinical corroboration, and mechanism of action analyses

Multi-omic network analysis identifies dysregulated neurobiological pathways in opioid addiction

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

Machine-learning Repurposing of DrugBank Compounds for Opioid Use Disorder

IUPHAR review: Recent progress in the development of Mu opioid receptor modulators to treat opioid use disorders

Machine-learning analysis of opioid use disorder informed by MOR, DOR, KOR, NOR and ZOR-based interactome networks

An emerging multi-omic understanding of the genetics of opioid addiction

Personalized medicine and opioid use disorder

CpH methylome analysis in human cortical neurons identifies novel gene pathways and drug targets for opioid use disorder

Insights into the Mechanisms Underlying Opioid Use Disorder and Potential Treatment Strategies

Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex

Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date

AI Derived Therapeutic Development for the Treatment of Opioid Use Disorder

Multi-objective Molecular Optimization for Opioid Use Disorder Treatment Using Generative Network Complex

Multiobjective Molecular Optimization for Opioid Use Disorder Treatment Using Generative Network Complex

Opioid use disorder: current trends and potential treatments

Pharmacological Characterization of 17-Cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) As a Dual Selective MOR/KOR Ligand with Potential Applications in Treating Opioid Use Disorder.

Identifying novel gene dysregulation associated with opioid overdose death: A meta-analysis of differential gene expression in human prefrontal cortex

Multiscale Topology in Interactomic Network: From Transcriptome to Antiaddiction Drug Repurposing

Angiogenic gene networks are dysregulated in opioid use disorder: evidence from multi-omics and imaging of postmortem human brain